Phase I-II trial of high-dose melphalan in previously untreated stage III multiple myeloma: Cancer and Leukemia Group B study 8512.

Source:http://linkedlifedata.com/resource/pubmed/id/1735010

Download in:

View as

General Info

PMID
1735010